Home > Financial Ratios > KOPRAN

KOPRAN
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for KOPRAN
Please provide your vote to see the results

KOPRAN Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 62.27-44.02-1.77110.80-4.18

What is the latest Core EBITDA Growth ratio of KOPRAN ?

The latest Core EBITDA Growth ratio of KOPRAN is 62.27 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202462.27
Mar2023-44.02
Mar2022-1.77
Mar2021110.80
Mar2020-4.18

How is Core EBITDA Growth of KOPRAN Trending?

Years Core EBITDA Growth % Change
Mar2024 62.27
Positive
Mar2023 -44.02
Negative
Mar2022 -1.77
Negative
Mar2021 110.8
Positive
Mar2020 -4.18 -

Other Financial Ratios of KOPRAN


Compare Core EBITDA Growth ratio of peers of KOPRAN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KOPRAN ₹759.8 Cr 0.1% -13.1% -43.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


KOPRAN Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KOPRAN

0.1%

-13.1%

-43.3%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses